Karus Therapeutics Company
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.
Industry:
Gene therapy
Headquarters:
Chilworth, Hampshire, United Kingdom
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$10M to $50M
Register and Claim Ownership